What's new

Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised

Mar 14, 2025 - 15:23
 0
Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised
Read More

Tags:

Previous Article

FBI and other agencies investigate fire at Bayer executive's NJ home: reports

Next Article

An Eating and Drinking Guide to Venice, Minus the Tourists

Related Posts

Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

PRIME: priority medicines

PRIME: priority medicines

Feb 9, 2025  0